Mucormycosis: a dreaded complication of COVID-19.

Covid-19 pandemic is in a massive second wave in India. The new variant is considered more infectious. Diabetic patients are considered more vulnerable to develop some of the complications of acute Covid-19 infections. Furthermore, steroids are being used in the treatment of Covid-19 related pneumonia in a large number of patients. Hence, secondary fungal infections are being increasing observed, with very high mortality. We present the clinical, imaging and histopathological features in a diabetic patient who recovered from acute Covid-19 infection. However, he developed palatal and maxillary mucormycosis. Mucosal debridement, sinus surgery and antifungal treatment led to a satisfactory outcome.